Reduced antimicrobial prescribing during autogenous staphylococcal bacterin therapy: a retrospective study in dogs with pyoderma

Wilson, A; Allers, N; Lloyd, D H; Bond, R; Loeffler, A

Abstract

Autogenous staphylococcal bacterins are commonly mentioned as treatment for canine recurrent pyoderma but little is known about their efficacy. This retrospective study describes use and assesses efficacy of an autogenous Staphylococcus (pseud)intermedius bacterin in dogs with pyoderma. Frequency and duration of systemic antimicrobial therapy were compared 12 months before and after starting bacterin (Wilcoxon signed-rank test) with data extracted from general practice medical histories.

Citation

Wilson, A., Allers, N., Lloyd, D. H., Bond, R., & Loeffler, A. (2019). Reduced antimicrobial prescribing during autogenous staphylococcal bacterin therapy: a retrospective study in dogs with pyoderma. Veterinary Record, 184(24), https://doi.org/10.1136/vr.105223

• Journal Article Type: Article
• Acceptance Date: Mar 14, 2019
• Publication Date: May 2, 2019
• Deposit Date: May 16, 2019
• Publicly Available Date: May 17, 2019
• Journal: Veterinary Record
• Print ISSN: 0042-4900
• Publisher: BMJ Publishing Group
• Peer Reviewed: Peer Reviewed
• Volume: 184
• Issue: 24
• DOI: https://doi.org/10.1136/vr.105223
• Public URL: https://rvc-repository.worktribe.com/output/1382529